-
Ferring appoints Jan Lundberg to Group Board
in PRESS RELEASE 2021 onFerring Pharmaceuticals announced today that Jan Lundberg has been appointed to the Ferring Group Board, effective January 2021, as a non-executive director and Chairman of the Research and Development Committee, following the retirement of John Patterson…
-
Simple Pharma acquires Testavan® and Vitaros®, two established men’s health brands, from Ferring
in STATEMENT 2021 onBy divesting its rights to Simple Pharma on this transaction, Ferring is able to focus on areas of high unmet need to bring the most value to patients and healthcare professionals. Testavan® (transdermal testosterone gel 2%) is a testosterone…
-
Ferring appoints Mirjam Mol-Arts to Executive Committee
in PRESS RELEASE 2020 onFerring Pharmaceuticals announced today that Mirjam Mol-Arts, previously Senior Vice President, Global Development, has been appointed to the position of Executive Vice President, Chief Science Officer and Chief Medical Officer.
-
Ferring Statement on the COVID-19 (novel coronavirus disease) Pandemic and Reproductive Medicine
in STATEMENT 2020 onThe health and safety of our patients, our employees and their families are Ferring’s number one priority. As the situation regarding COVID-19 (novel coronavirus disease) is evolving rapidly, Ferring is committed to following appropriate global, regional and local medical authority guidance to prevent infection spread and to keep patients, our employees and their families safe.
Author archive for caju
Articles by: caju
